Clinical Trial Update: St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety [Phase 2]

View source ↗

Summary

This document notes the completion of a Phase 2 clinical trial evaluating St. John's Wort and Kava for major depressive disorder with comorbid anxiety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Kava (Piper methysticum)
• St. John's Wort (Hypericum perforatum)

Snippet

Sponsor: The University of Queensland | Conditions: Depressive Disorder, Major, Anxiety Disorders | Phase 2 | Status: COMPLETED